Fig. 2From: Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatmentAMDE screening of active compounds in YGL capsule, the YGL capsule compound-compound target network, and HB disease target mining. a Active compounds according to the OB, CACO-2, DL, and HL screening results. b Venn diagram of the active compounds according to the four indicator values (OB, CACO-2, DL, and HL). c The YGL capsule compound target network consisted of 250 compound targets and 122 compounds (stars represent compounds, yellow squares represent targets). d The retrieval results of HB targets for different disease databases. e Venn diagram of the retrieval results of HB targets of different disease databasesBack to article page